<DOC>
	<DOCNO>NCT00711776</DOCNO>
	<brief_summary>This study design show bioequivalence Current New formulation Aciclovir cream 5 % keratin layer epidermis Japanese Subjects</brief_summary>
	<brief_title>Bioequivalence Study Aciclovir 5 % Cream Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Healthy Japanese adult male 20 55 year age , inclusive . Healthy subject define individual free clinically significant disease determine medical history , physical examination , clinical laboratory examination , vital sign , 12lead ECG , immunology test urinary drug screen test . Bodyweight &gt; 50 kg body mass index ( BMI ) 18.5 28.0 screening . Subjects must capable provide write informed consent , include compliance requirement restriction list consent form . Baseline QTc interval &lt; 450 msec . Nonsmoker exsmoker cease smoke least 6 month . Clinical laboratory examination ( AST , ALT , ALP GGT ) screen within normal range . The subject able attend visit complete study . Any clinically relevant abnormality identify screen physical examination , vital sign measurement , 12lead ECG record and/or clinical laboratory examination deem principal investigator and/or medical monitor make subject ineligible inclusion safety concern . History regular alcohol consumption exceed , average , 14 drinks/week ( 1 drink = 5 ounce ( 150 mL ) wine 350 mL beer 1.5 ounce ( 45 mL ) 80 proof distil spirit ) within 6 month screen . Positive urine drug screening . Positive syphilis , HIV antibody , Hepatitis B surface antigen , Hepatitis C antibody HTLV1 antibody screen . Donation blood excess 400mL within 4 month 200mL within 1 month prior screen . History drug abuse , current condition drug abuse alcoholism . Participation clinical study postmarketing study investigational noninvestigational product device within 4 month precede first application study medication . Participation another clinical study postmarketing study subject expose investigational noninvestigational product device . History asthma , anaphylaxis anaphylactoid reaction , severe allergic response . The subject allergy drug idiosyncrasy . This exclude pollen allergy without current symptom . At part obtain keratinize layer , exanthem , pigment abnormality , skin symptom wound and/or excessive sunburn . History clinically significant itching , erythema and/or rash paster .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Aciclovir cream 5 %</keyword>
	<keyword>Volunteer</keyword>
	<keyword>Japanese</keyword>
	<keyword>Male</keyword>
	<keyword>Bioequivalence</keyword>
</DOC>